Restenosis after PCI. Part 1: pathophysiology and risk factors
Restenosis is a complex disease for which the pathophysiological mechanisms have not yet
been fully elucidated, but are thought to include inflammation, proliferation, and matrix …
been fully elucidated, but are thought to include inflammation, proliferation, and matrix …
Coronary in-stent restenosis: current status and future strategies
HC Lowe, SN Oesterle, LM Khachigian - Journal of the American College of …, 2002 - jacc.org
In-stent restenosis (ISR) is a novel pathobiologic process, histologically distinct from
restenosis after balloon angioplasty and comprised largely of neointima formation. As …
restenosis after balloon angioplasty and comprised largely of neointima formation. As …
Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography
Objective Systematic investigation of restenosis after percutaneous coronary intervention
(PCI) with bare metal stents (BMS) or first or second generation drug eluting stents (DES) in …
(PCI) with bare metal stents (BMS) or first or second generation drug eluting stents (DES) in …
[PDF][PDF] An introduction to classification and regression tree (CART) analysis
RJ Lewis - Annual meeting of the society for academic emergency …, 2000 - Citeseer
A common goal of many clinical research studies is the development of a reliable clinical
decision rule, which can be used to classify new patients into clinically-important categories …
decision rule, which can be used to classify new patients into clinically-important categories …
[HTML][HTML] A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease
Background Restenosis after coronary stenting necessitates repeated percutaneous or
surgical revascularization procedures. The delivery of paclitaxel to the site of vascular injury …
surgical revascularization procedures. The delivery of paclitaxel to the site of vascular injury …
Determination of layer-specific mechanical properties of human coronary arteries with nonatherosclerotic intimal thickening and related constitutive modeling
GA Holzapfel, G Sommer… - American Journal of …, 2005 - journals.physiology.org
At autopsy, 13 nonstenotic human left anterior descending coronary arteries [71.5±7.3
(mean±SD) yr old] were harvested, and related anamnesis was documented …
(mean±SD) yr old] were harvested, and related anamnesis was documented …
Guidelines for percutaneous coronary interventions: the Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology
S Silber, P Albertsson, FF Avilés… - European heart …, 2005 - academic.oup.com
In patients with stable CAD, PCI can be considered a valuable initial mode of
revascularization in all patients with objective large ischaemia in the presence of almost …
revascularization in all patients with objective large ischaemia in the presence of almost …
Novel high-strength, low-alloys Zn-Mg (< 0.1 wt% Mg) and their arterial biodegradation
It is still an open challenge to find a biodegradable metallic material exhibiting sufficient
mechanical properties and degradation behavior to serve as an arterial stent. In this study …
mechanical properties and degradation behavior to serve as an arterial stent. In this study …
Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial
ContextCompared with bare metal stents, drug-eluting stents reduce restenosis in
noncomplex lesions. The utility of drug-eluting stents has not been evaluated in more difficult …
noncomplex lesions. The utility of drug-eluting stents has not been evaluated in more difficult …
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial
Background—The safety and efficacy of the slow-release, polymer-based, paclitaxel-eluting
stent after implantation in a broad cross section of de novo coronary lesions at 1 year are …
stent after implantation in a broad cross section of de novo coronary lesions at 1 year are …